Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”

الملخص EN

Recently, Sue et al.

published an open-label study, aiming to assess the efficacy of a 7-day first-line Helicobacter pylori (H.

pylori) eradication regimen with vonoprazan (VPZ), clarithromycin (CAM), and metronidazole (MNZ), in patients with penicillin allergy [1].

In a letter to the editor, Kashani and Abadi raised several criticisms of this article [2].

The authors responded [3], but we want to focus on two not redundant points.